DarioHealth Corp

Company Profile

DarioHealth Corp had its IPO on 2014-10-06 under the ticker symbol DRIO.

The company operates in the Healthcare sector and Diagnostics & Research industry. DarioHealth Corp has a staff strength of 241 employees.

Stock update

Shares of DarioHealth Corp opened at $3.92 at the start of the last trading session i.e. 2023-03-19.

The stocks traded within a range of $3.87 - $4.08, and closed at $4.03.

This is a 0% increase from the previous day's closing price.

A total volume of 162,700 shares were traded at the close of the day’s session.

In the last one week, shares of DarioHealth Corp have slipped by -9.23%.

DarioHealth Corp's Key Ratios

DarioHealth Corp has a market cap of $104.26 million, indicating a price to book ratio of 1.1263 and a price to sales ratio of 3.4241.

In the last 12-months DarioHealth Corp’s revenue was $27.66 million with a gross profit of $14.01 million and an EBITDA of $-52093000. The EBITDA ratio measures DarioHealth Corp's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, DarioHealth Corp’s operating margin was -205.42% while its return on assets stood at -32.28% with a return of equity of -75.14%.

In Q4, DarioHealth Corp’s quarterly earnings growth was a positive 0% while revenue growth was a positive 13%.

DarioHealth Corp’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

0

Its diluted EPS in the last 12-months stands at $-2.43 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into DarioHealth Corp’s profitability.

DarioHealth Corp stock is trading at a EV to sales ratio of 2.5387 and a EV to EBITDA ratio of -1.0225. Its price to sales ratio in the trailing 12-months stood at 3.4241.

DarioHealth Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$119.19 million

Total Liabilities

$19.35 million

Operating Cash Flow

$-59000.00

Capital Expenditure

$398999.56

Dividend Payout Ratio

0%

DarioHealth Corp ended 2023 with $119.19 million in total assets and $0 in total liabilities. Its intangible assets were valued at $119.19 million while shareholder equity stood at $80.00 million.

DarioHealth Corp ended 2023 with $910000.00 in deferred long-term liabilities, $19.35 million in other current liabilities, 3000.00 in common stock, $-285850000.00 in retained earnings and $41.64 million in goodwill. Its cash balance stood at $49.36 million and cash and short-term investments were $49.36 million. The company’s total short-term debt was $293,000 while long-term debt stood at $18.11 million.

DarioHealth Corp’s total current assets stands at $65.52 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $6.42 million compared to accounts payable of $2.32 million and inventory worth $7.96 million.

In 2023, DarioHealth Corp's operating cash flow was $-59000.00 while its capital expenditure stood at $398999.56.

Comparatively, DarioHealth Corp paid $0 in dividends in 2023.

Other key metrics

Current Trading Price

$4.03

52-Week High

$7.692

52-Week Low

$3.53

Analyst Target Price

$12.75

DarioHealth Corp stock is currently trading at $4.03 per share. It touched a 52-week high of $7.692 and a 52-week low of $7.692. Analysts tracking the stock have a 12-month average target price of $12.75.

Its 50-day moving average was $5.09 and 200-day moving average was $5.1 The short ratio stood at 12.59 indicating a short percent outstanding of 0%.

Around 1815.8% of the company’s stock are held by insiders while 3093.9% are held by institutions.